Transplantation for cholangiocarcinoma: when and for whom?
about
Serum albumin predicts survival in patients with hilar cholangiocarcinomaRecent advances in the regulation of cholangiocarcinoma growthUpdate on the management of cholangiocarcinoma.R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitroTumor markers as a diagnostic key for hilar cholangiocarcinoma.Hilar cholangiocarcinoma: diagnosis, treatment options, and management.Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.Preneoplastic conditions underlying bile duct cancer.Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma.Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experienceEfficacy and safety of liver transplantation in patients with cholangiocarcinoma: a systematic review and meta-analysis.Cholangiocarcinoma--controversies and challenges.Primary Sclerosing Cholangitis: Current and Future Management Strategies.Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.Tumor growth effects of rapamycin on human biliary tract cancer cells.Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol.Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case.Outcome of Transplant-fallout Patients With Unresectable CholangiocarcinomaExcellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation.Salinomycin inhibits cholangiocarcinoma growth by inhibition of autophagic flux.Total hepatectomy, pancreatoduodenectomy, and living donor liver transplantation using innovative vascular reconstruction for unresectable cholangiocarcinoma.
P2860
Q33726891-8CCDB110-0482-4A37-9BCA-A932471D01D0Q33994814-00DF71BA-7F3E-4EF8-B3EC-117773AE81EAQ34153255-D11CEE76-093E-4302-B25F-35245FE5131CQ34384390-8F75B124-2C83-4F74-83DD-7E9705C12818Q34443640-671C8460-C5EC-48D8-B952-F8A3B812BEAEQ34624362-048BDC1D-2679-4C4B-8ACA-618ABF17561AQ34661001-DB75595B-154C-4BC0-A947-F0C5E7F205BCQ35607681-014EF5E9-C0E6-4F05-A131-0FE8DD475F5AQ36199767-F2F2DDC9-A2FB-408C-9C92-A88CF5895A69Q37246190-84AC81D9-AACC-4CEE-88AA-13EDE1CF9653Q37316693-4D1CECC7-DF7C-4714-B0DF-4B31F728A2BCQ37355544-C6FB6079-3400-4B2B-9B7D-21A9C7B4DEBCQ37480883-7AB091D0-7AE7-45AD-935F-6360EA477C7AQ37851065-92467B28-9E97-4BBB-AB5B-D7B1B0742AA7Q37860916-8278F4A7-2169-4A47-AB7E-0929FAF9F4E1Q38107484-F85DB4B9-473A-4BB2-B2DC-7E2E22B34EB1Q38212836-62BB0D6D-A8D3-4A6C-87F2-89EF13CF87E9Q39327387-CBE5D509-5E32-47C2-A358-5E5AE81E190DQ39579321-91C342B1-3B45-4AF0-B43C-AD6C828843EAQ41578500-DD77AAA7-944F-4EA0-B1C3-A5503F34E864Q42015945-2B066F89-EC87-41E9-BAF0-6F1446B699DAQ42162594-E1EFA7E2-56AF-4D37-B43E-D186F72883D9Q48289479-C1A5462C-C669-466F-95C6-8D2B282A3A1EQ49188840-FD8E9CC3-C265-437F-B2B4-B96E3AACE680Q53059422-932ACDB3-9AF7-4BFD-9363-D0B1FDE1B68E
P2860
Transplantation for cholangiocarcinoma: when and for whom?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transplantation for cholangiocarcinoma: when and for whom?
@en
Transplantation for cholangiocarcinoma: when and for whom?
@nl
type
label
Transplantation for cholangiocarcinoma: when and for whom?
@en
Transplantation for cholangiocarcinoma: when and for whom?
@nl
prefLabel
Transplantation for cholangiocarcinoma: when and for whom?
@en
Transplantation for cholangiocarcinoma: when and for whom?
@nl
P2093
P1476
Transplantation for cholangiocarcinoma: when and for whom?
@en
P2093
Charles B Rosen
David J Rea
David M Nagorney
Julie K Heimbach
P304
325-37, ix
P356
10.1016/J.SOC.2008.12.008
P577
2009-04-01T00:00:00Z